|
Press Releases |
|
 |
|
Tuesday, September 6, 2022 |
|
Oculis announces publication of Phase 2 data showing topical OCS-01 improves macular thickness and visual acuity in patients with diabetic macular edema |
Oculis S.A., ('Oculis') a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, announces that the Phase 2 DX-211, a randomized, double blinded, multi-center and vehicle controlled clinical trial assessing the safety and efficacy of topical OCS-01 in patients with Diabetic Macular Edema (DME) (NCT05343156) has been published by the Acta Ophthalmologica journal. more info >> |
|
Tuesday, August 23, 2022 |
|
Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease |
Oculis S.A., ('Oculis') a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, announces that the results of the double blinded more info >> |
|
Wednesday, June 29, 2022 |
|
Oculis Announces First Patient Enrolled in Phase 3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract Surgery |
Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations more info >> |
|
Wednesday, March 2, 2022 |
|
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics |
Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, and Accure Therapeutics, a private translational neuroscience R&D company more info >> |
|
Tuesday, February 8, 2022 |
|
Oculis appoints Dr. Bastian Dehmel as Chief Development Officer |
Oculis S.A. ("Oculis"), a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to improve the sight and lives of patients, announces the further strengthening of the Company's executive leadership team with the appointment of Dr. Bastian Dehmel as global Chief Development Officer more info >> |
|
Wednesday, January 5, 2022 |
|
Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China) |
Oculis S.A. ("Oculis"), a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to improve the sight and lives of patients, announces the appointment of Mr. Webb Ding as global Chief Operating Officer and General Manager, China, with effect from February 1, 2022. more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
Singapore to Host the 24th Cyber Security Summit: Addressing Emerging Threats and AI-Driven Security
Mar 6, 2025 10:16 HKT/SGT
|
|
|
Doubleview Gold Corp Announces Collaboration with Her Excellency Sheikha Sara Nasser Al-Thani CEO of Qmission W.L.L. Qatar
Mar 6, 2025 09:09 HKT/SGT
|
|
|
Register Now: analytica Vietnam's Largest Edition & Must-See Innovations!
Mar 6, 2025 07:32 HKT/SGT
|
|
|
Hong Kong International Jewellery Show opens today showcasing global innovative designs
Mar 5, 2025 23:01 HKT/SGT
|
|
|
Nissin Foods (Hong Kong) Charity Fund Supporting Talents in Food and Nutritional Sciences for the Third Consecutive Year
Mar 5, 2025 23:01 HKT/SGT
|
|
|
Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters
Mar 5, 2025 22:58 HKT/SGT
|
|
|
General Atomics Introduces Quadratix Software Enterprise
Mar 5, 2025 22:42 HKT/SGT
|
|
|
HighTide Therapeutics Announces Publication of Phase 2 Study of Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes Mellitus in JAMA Network Open
Mar 5, 2025 21:51 HKT/SGT
|
|
|
Giftify, Inc. Launches Sports Ticket & Merchandise Savings Platform as Fan Expenses Surge
Mar 5, 2025 21:30 HKT/SGT
|
|
|
Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program
Mar 5, 2025 21:15 HKT/SGT
|
|
|
Historic Global Anti-Scam Summit Convenes in London to Combat Escalating Online Fraud
Mar 5, 2025 19:07 HKT/SGT
|
|
|
General Atomics Acquires North Point Defense
Mar 5, 2025 18:58 HKT/SGT
|
|
|
Chery Auto Launches an IPO on HKEX - Fundamentals Driving Long-term Value Growth
Mar 5, 2025 15:28 HKT/SGT
|
|
|
Unmanned Aerial Vehicles Being Developed by MHI Used in Demonstration of Automated Transport and Unloading of Heavy Cargo in Disaster Areas
Mar 5, 2025 16:11 JST
|
|
|
HODL 2025 Announces Its Biggest Web3 Gathering in Dubai
Mar 5, 2025 11:35 HKT/SGT
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|